Neogenomics Stock Forecast

Buy or Hold candidate since May 20, 2026 Gain 66.74%

The NeoGenomics stock price gained 2.34% on the last trading day (Thursday, 16th Jul 2026), rising from $14.50 to $14.84. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.70% from a day low at $14.45 to a day high of $14.99. The price has risen in 5 of the last 10 days but is still down by -0.87% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $61.23 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 84.50% during the next 3 months and, with a 90% probability hold a price between $23.40 and $29.76 at the end of this 3-month period.

NEO Signals & Forecast

The NeoGenomics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $14.39 and $12.44. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -2.11%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for NeoGenomics stock

NeoGenomics finds support from accumulated volume at $14.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.535 between high and low, or 3.70%. For the last week, the stock has had daily average volatility of 4.01%.

Our recommended stop-loss: $14.21 (-4.25%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (NEO) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect NeoGenomics to open at $14.76, and during the day (based on 14 day Average True Range), to move between $14.51 and $15.17, which gives a possible trading interval of +/-$0.655 (+/-4.51%) up or down from last closing price. If NeoGenomics takes out the full calculated possible swing range there will be an estimated 4.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $14.97 (0.88%) than the support at $14.17 (4.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is NeoGenomics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for NeoGenomics stock to perform well in the short-term.

Current score: 3.030 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $14.76 ( 0.550%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk